Top Markets
#1 PulseChain PulseChain +45.13%
#2 Glidr Glidr +11.05%
#3 Fake World Assets Fake World Assets +9.47%
#4 Meteora Meteora +7.99%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.90%
#6 eCash eCash +6.72%
#7 Qkacoin Qkacoin +6.49%
#8 OPENLOOT OPENLOOT +5.89%
#9 Velvet Velvet +5.57%
#10 Tornado Cash Tornado Cash +5.56%
Coin of the day
PulseChain PulseChain
설정
언어
한국어
통화
USD
테마
Family Office of America Inc. Family Office of America Inc.

Family Office of America Inc.

FOFA
주식 순위 #28261
Family Office of America, Inc. specializes in delivering a broad spectrum of... Family Office of America, Inc. specializes in delivering a broad spectrum of services designed for family offices. Their expertise spans accounting and tax strategy, comprehensive wealth and asset administration, meticulous estate planning, robust asset protection, insurance guidance, and sophisticated investment banking support. Previously operating as Qualis Innovations, Inc., the organization officially adopted its current name, Family Office of America, Inc., in December 2024. The company's main operational hub is situated in Centennial, Colorado.
주가
$0.91
마지막 동기화: 2026-08-18
시가총액
$27.62M
변동 (1일)
0.00%
변동 (1년)
225.00%
국가
US
거래 Family Office of America Inc. (FOFA)

카테고리

Healthcare
Family Office of America Inc. (FOFA)의 매출
Aug 2026 기준 매출 TTM: 0
Family Office of America Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Family Office of America Inc.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US